BioGenomics Ltd.
Rajendra Patkar is a seasoned pharmaceutical executive with extensive experience in various leadership roles within the industry. Currently serving as the President of Biopharma Global Business Development and Licensing at BioGenomics Ltd. since December 2016, Rajendra previously held key positions at RPG Life Sciences Ltd. as Chief Executive of Global Formulations, where significant sales growth and market rank improvements were achieved. At JB Chemicals & Pharma, Rajendra served as Director of the Domestic Business Unit, successfully launching major brands and achieving substantial revenue growth. Prior roles include Vice President at Wockhardt Ltd., GM of the Respiratory SBU at Kopran Limited, and GM of Marketing at Nicholas Piramal India Ltd. A graduate of Jamnalal Bajaj Institute of Management Studies with a Master of Management Studies in Marketing, Rajendra also holds a Bachelor of Pharmacy from The Bombay College of Pharmacy and is pursuing a PhD in Pharma Marketing from Mumbai University.
BioGenomics Ltd.
Biogenomics is a Science driven enterprise. Led by eminent scientists, business professionals and a focussed team of molecular biologists, microbiologists and protein engineers, Biogenomics has, in a short span of 10 years, developed dozens of Biopharmaceuticals and Biotech products. Biogenomics has a strong scientific base and we aim to innovate and adapt to the changing socio-economic demands of healthcare, at every stage, from Laboratory Bench to Manufacturing Shopfloor. Young, rapidly growing biopharmaceutical firm, Biogenomics is on a trajectory of delivering excellence in healthcare. We draw from our core desire of wanting to enrich lives with high-quality and valuable drugs. Our mission is to deliver affordable healthcare and to do all we can to ensure patient access to expensive specialty pharmaceuticals and biological drugs.